OIG: Medicare Spent $366 Million More by Including Self-Administered Drugs in Part B Calculations

Drug Industry Daily
A A
Medicare and its beneficiaries would face significantly lower costs for drugs if the Centers for Medicare and Medicaid Services excluded noncovered versions of drugs while setting Part B drug payments, according to the HHS Office of Inspector General.

To View This Article:

Login

Subscribe To Drug Industry Daily